Parse Biosciences introduces workflow for immune repertoire and transcriptome analysis: Seattle Saturday, January 24, 2026, 15:00 Hrs [IST] Parse Biosciences, the leading provider ...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced the launch of a fully integrated immune repertoire and ...

Parse Biosciences & Graph Therapeutics partner to build large functional immune perturbation atlas: Seattle Thursday, January 22, 2026, 11:00 Hrs [IST] Parse Biosciences, a global ...

CVS Health® today announced key milestones in its ongoing effort to make health care simpler and more affordable for American ...

CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed ...

Single-cell analyses have emerged as powerful tools for studying cellular heterogeneity and gene regulation. Single-cell chromatin accessibility sequencing (scCAS) is a key technology that enables the ...

The development of humans and other animals unfolds gradually over time, with cells taking on specific roles and functions ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Thanks to a new approach, more labs will be able to access the power of single-cell sequencing — gaining insights into complex biological processes otherwise obscured in bulk samples. Not so long ago, ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

The market for microbiome sample preparation technology presents opportunities driven by demand for personalized medicine, ...

Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development ...